This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Indiana University. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Li-Fan Zeng: Innovator in Autoimmune Disease Treatment
Introduction
Li-Fan Zeng is a prominent inventor based in Indianapolis, IN (US), known for his significant contributions to the field of autoimmune disease treatment. With a total of 4 patents, Zeng has focused his research on innovative methods to combat diseases such as Systemic Lupus Erythematosus (SLE).
Latest Patents
Zeng's latest patents include groundbreaking methods for treating autoimmune and/or glomerulonephritis-associated diseases using SHP2 inhibitors. These methods involve administering an oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitor specifically for the treatment of SLE. His work in this area has the potential to significantly improve therapeutic options for patients suffering from these challenging conditions.
Career Highlights
Li-Fan Zeng is affiliated with Indiana University, where he continues to advance his research and innovation in the medical field. His dedication to understanding and treating autoimmune diseases has positioned him as a key figure in this area of study.
Collaborations
Zeng collaborates with notable colleagues, including Zhong-Yin Zhang and Maria Kontaridis, who contribute to his research efforts and enhance the impact of his work.
Conclusion
Li-Fan Zeng's innovative approaches to treating autoimmune diseases highlight his commitment to advancing medical science. His patents and collaborations reflect a promising future for patients affected by these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile